Chile vs Nigeria: Patent applications, residents
Patent applications, residents over time
- Chile
- Nigeria
How they compare
Nigeria currently reports 410 against 390 in Chile, a difference of 20.
That makes Nigeria's figure about 1.1 times Chile's.
The two have swapped places 1 time across 10 shared years of data; in 1985 it was Chile ahead.
Chile ranks 51st and Nigeria ranks 49th of 139 countries.
Across the 4 decades both report, Chile averaged higher in 3 and Nigeria in 1.
Head to head by decade
| Decade | Chile | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 122 | 10 | 112 | Chile |
| 1990s | 169 | 12 | 157 | Chile |
| 2010s | 381.43 | 166 | 215.43 | Chile |
| 2020s | 372 | 410 | 38 | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher patent applications, residents, Chile or Nigeria?
- Nigeria, at 410 against 390 in Chile as of 2020.
- What is the difference in patent applications, residents between Chile and Nigeria?
- 20, with Nigeria ahead.
- How many years of comparable data are there for Chile and Nigeria?
- 10 years are reported by both, from 1985 to 2020.
- How do Chile and Nigeria rank globally for patent applications, residents?
- Chile ranks 51st and Nigeria ranks 49th of 139 countries.
- Where does this data come from?
- WIPO Patent Report: Statistics on Worldwide Patent Activity, World Intellectual Property Organization (WIPO), note: The International Bureau of WIPO assumes no responsibility with respect to the trans, published as Patent applications, residents. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Patent applications are worldwide patent applications filed through the Patent Cooperation Treaty procedure or with a national patent office for exclusive rights for an invention--a product or process that provides a new way of doing something or offers a new technical solution to a problem. A patent provides protection for the invention to the owner of the patent for a limited period, generally 20 years.